Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 16, 2021

SELL
$49.14 - $59.89 $11,793 - $14,373
-240 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$42.19 - $51.5 $10,125 - $12,360
240 New
240 $12,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Ade, LLC Portfolio

Follow Ade, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ade, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ade, LLC with notifications on news.